Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Peptide
-
- Target See all Galectin 9 (LGALS9) products
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YPHPAYPMPF ITTILGGLYP SKSILLSGTV LPSAQRFHIN LCSGNHIAFH
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS9 antibody,
Alternative Names: LGALS9 control peptide, LGALS9 antibody Blocking Peptide, Anti-LGALS9 Blocking Peptide, Lectin Galactoside-Binding Soluble 9 Blocking Peptide, Galectin 9 Blocking Peptide, ECALECTIN Blocking Peptide, HUAT Blocking Peptide, MGC117375 Blocking Peptide, MGC125973 Blocking Peptide, MGC125974 Blocking Peptide, galectin-9 Blocking Peptide, LGALS9, LGALS-9, LGALS 9, LGALS-9 Blocking Peptide, LGALS 9 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
- Background
- The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
- Molecular Weight
- 39 kDa
-